Literature DB >> 11786081

Cytokine-induced expression of tPA is differentially modulated by NO and ROS in rat mesangial cells.

Wolfgang Eberhardt1, Karl-Friedrich Beck, Josef Pfeilschifter.   

Abstract

BACKGROUND: Dysregulated expression of diverse proteases and their specific inhibitors is critical for the increase in extracellular matrix accumulation that accompanies chronic inflammatory and sclerotic processes within the renal mesangium. Within the activating cascade of several proteases, the plasminogen system plays an important role.
METHODS: We tested for modulatory effects of the nitric oxide (NO) donors S-nitroso-N-acetyl-D,L-penicillamine and DETA-NONOate, and the superoxide-generating system hypoxanthine/xanthine oxidase (HXXO) on the expression and activity of tissue plasminogen activator (tPA) by ELISA and Northern blotting.
RESULTS: Interleukin-1beta (IL-1beta)-induced tPA and plasminogen activator inhibitor (PAI)-1 mRNA and supernatant tPA antigen were significantly inhibited by both NO donors, which resulted in a net decrease in the IL-1beta-evoked tPA enzyme activity in the conditioned media. Addition of the NO-synthase inhibitor N-monomethyl l-arginine markedly increased the cytokine-triggered tPA- and PAI-1 mRNA levels, respectively. In contrast, HXXO caused a marked amplification of the IL-1beta-induced steady-state tPA mRNA level and tPA enzyme activity that was blocked by catalase. Since MnTBAP, a superoxide dismutase mimetic, had no effects on the amplification of mRNA levels, we suggest that H2O2 is the candidate reactive oxygen species (ROS) responsible for the potentiation of IL-1beta-triggered tPA and PAI-1 expression.
CONCLUSIONS: The temporal relationship between NO and ROS generation is a critical step in the modulation of tPA and PAI-1 expression in mesangial cells and may account for a dysregulation of matrix turnover during inflammatory processes in the renal mesangium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786081     DOI: 10.1046/j.1523-1755.2002.00087.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR.

Authors:  El-Sayed Akool; Hartmut Kleinert; Farid M A Hamada; Mohamed H Abdelwahab; Ulrich Förstermann; Josef Pfeilschifter; Wolfgang Eberhardt
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

2.  Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration.

Authors:  Colm Cunningham; David C Wilcockson; Suzanne Campion; Katie Lunnon; V Hugh Perry
Journal:  J Neurosci       Date:  2005-10-05       Impact factor: 6.709

3.  Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute paraquat intoxication.

Authors:  Su-Jin Seok; Su-Ji Kim; Hyo-Wook Gil; Jong-Oh Yang; Eun-Young Lee; Sae-Yong Hong
Journal:  J Korean Med Sci       Date:  2011-03-28       Impact factor: 2.153

Review 4.  Bench-to-bedside review: Ventilation-induced renal injury through systemic mediator release--just theory or a causal relationship?

Authors:  Jan Willem Kuiper; Rosanna Vaschetto; Francesco Della Corte; Frans B Plötz; A B Johan Groeneveld
Journal:  Crit Care       Date:  2011-08-16       Impact factor: 9.097

5.  DPP-4 inhibitor attenuates toxic effects of indoxyl sulfate on kidney tubular cells.

Authors:  Wei-Jie Wang; Chen-Hung Chang; Mao-Feng Sun; Sheng-Feng Hsu; Ching-Sung Weng
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

Review 6.  Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases.

Authors:  Yingqing Chen; Shuo Yuan; Yuying Cao; Guangyao Kong; Feng Jiang; You Li; Qi Wang; Minli Tang; Qinggao Zhang; Qianqian Wang; Liping Liu
Journal:  Oxid Med Cell Longev       Date:  2021-09-20       Impact factor: 6.543

7.  Different prevalence of chronic-non-infectious diseases.

Authors:  Am El-Tawil
Journal:  Iran J Public Health       Date:  2010-03-31       Impact factor: 1.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.